Production (Stage)
Innate Pharma S.A.
IPHA
$2.08
-$0.09-4.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 83.62M | 90.08M | 98.36M | 99.04M | 102.20M |
| Total Receivables | 1.70M | 1.83M | 14.82M | 14.92M | 51.39M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.92M | 3.15M | 3.22M | 3.25M | 6.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 527.00K | 567.70K | 3.17M | 3.19M | 3.73M |
| Total Current Assets | 88.77M | 95.63M | 119.57M | 120.39M | 163.60M |
|
|
|||||
| Total Current Assets | 88.77M | 95.63M | 119.57M | 120.39M | 163.60M |
| Net Property, Plant & Equipment | 5.31M | 5.73M | 6.16M | 6.20M | 6.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 127.50K | 128.40K | 459.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.25M | 11.05M | 25.38M | 25.55M | 11.76M |
| Total Assets | 114.98M | 123.87M | 162.32M | 163.44M | 193.64M |
|
|
|||||
| Total Accounts Payable | 8.20M | 8.84M | 9.38M | 9.44M | 9.46M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.02M | 9.71M | 9.57M | 9.63M | 9.88M |
| Total Finance Division Other Current Liabilities | 16.93M | 18.24M | 22.01M | 22.16M | 24.47M |
| Total Other Current Liabilities | 16.93M | 18.24M | 22.01M | 22.16M | 24.47M |
| Total Current Liabilities | 34.15M | 36.79M | 40.96M | 41.24M | 43.81M |
|
|
|||||
| Total Current Liabilities | 34.15M | 36.79M | 40.96M | 41.24M | 43.81M |
| Long-Term Debt | 22.97M | 24.74M | 28.30M | 28.49M | 33.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 107.70K | 116.00K | 175.70K | 176.90K | 386.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.61M | 52.37M | 62.04M | 62.47M | 58.24M |
| Total Liabilities | 105.83M | 114.01M | 131.47M | 132.38M | 136.27M |
|
|
|||||
| Common Stock & APIC | 409.12M | 440.74M | 417.98M | 420.86M | 429.20M |
| Retained Earnings | -400.00M | -430.92M | -387.50M | -390.18M | -372.38M |
| Treasury Stock & Other | 28.00K | 30.10K | 380.40K | 383.00K | 547.10K |
| Total Common Equity | 9.15M | 9.85M | 30.85M | 31.07M | 57.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.15M | 9.85M | 30.85M | 31.07M | 57.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.15M | 9.85M | 30.85M | 31.07M | 57.37M |
|
|
|||||